← Back to search results

planningFind a Tender · planning Update

Soft Market Testing Radiopharmacy Services Joint Venture

Buyer: Royal United Hospitals Bath NHS Foundation Trust →

BuyerRoyal United Hospitals Bath NHS Foundation Trust
Statusplanning
DeadlineNot published
ValueValue not published
Published28 May 2026

What is being bought

The Royal United Hospitals NHS Foundation Trust is exploring options to expand its Radiopharmacy Services to improve access to diagnostics, innovative treatment and research in Southwest England. Uniquely positioned on the M4/M5 corridor, the Trust has a state-of-the-art Pharmacy build intended to provide a comprehensive range of services including: 1. Cytotoxics (191 sq ft): mainly production of systemic anticancer therapy (SACT) and clinical trials for Onc/Haem 2. Monoclonal antibodies (180 sq ft): products for Biologics unit and chemo unit 3. Radiopharmacy unit (279sq ft): supply for Nuclear medicine diagnostics & treatment 4. Vacant clean room space originally intended for Gene Therapy (108 sq ft) As part of this appraisal, the Trust is evaluating a range of potential delivery and funding models, including the possibility of a Joint Venture or other form of partnership with a private sector organisation. The purpose of this soft market testing exercise is to gain insight into: • The level of interest from suppliers and investors in collaborating with the Trust • The range of commercial, technical and operational models available within the market • Key risks, dependencies and potential mitigation approaches • Options that best ensure service continuity • Indicative timelines and delivery pathways This exercise is being undertaken for information gathering purposes only and does not constitute a call for competition or form part of any formal procurement process. The responses received will be used to inform the Trust’s approach and any potential future procurement activity. Please note, Royal United Hospitals Bath NHS Foundation Trust reserves the right not to proceed with the procurement once this Pre-Engagement stage has been finalised.

Categories

Radioactive materials 09343000Radio-isotopes 09344000Pharmaceutical products 33600000Various medicinal products 33690000Pharmacy services 85149000

Lot details

Lot 1

No lot description published.

Statusplanning
Contract periodFrom 1 Jan 2027 to 1 Jun 2037

What is included

ItemCategoryQuantity
1Pharmacy services, Radio-isotopes, Pharmaceutical products, Various medicinal products, Radioactive materialsNot published

Comparable-procurement analytics

Benchmarked against retained Find a Tender procedures with CPV division 09. The category anchor is Radioactive materials (09343000); this is a deliberately broad market comparator. The comparison is shown at several levels rather than pretending one company or region is always the best benchmark.

Comparison setProceduresReported bids per procedureNamed award suppliersPrice evidence
Market: CPV division 091,8384 median · 34.4 average (667 of 1,838 with a bid count)5 average (769 of 1,838 with named award suppliers)Not published
Same buyer0Not publishedNot publishedNot published

“Reported bids” is an official aggregate, sometimes reported per lot; it is the closest available competition measure. “Named award suppliers” are winners, not all applicants.

Price-outcome signal

Not enough comparable procedures currently publish both a GBP tender value and a usable lowest-valid-bid value to calculate a responsible price-reduction benchmark. Tenderline deliberately does not infer a saving from named award suppliers or from missing award values.

Procurement strategy & market signals

Framework agreementNot published
Dynamic purchasing systemNot published
Competitive procurementNot published
Recurring requirementNot published
Procurement method rationaleNot published
Rationale classificationsNot published
Special regimeNot published
Covered byNot published
Submission policyNot published
Selection criteriaNot published
Risk detailsNot published

Planning & early market engagement

BudgetValue not published
No-engagement rationaleNot published
Planning documents1
Planning milestones1
MilestoneTypeDueStatus
Engagement with interested suppliers will be conducted on a one-to-one basis during the week commencing 15th and 22nd June. This will include an invite to a face-to-face meeting, along with an opportunity to visit and tour the Aseptic Unit. Interested parties are invited to express their interest via the Health service Family portal - https://atamis-1928.my.site.com/s/Welcome Please include a brief overview of your organisation, relevant experience and strategic ambition in Radiopharmaceutical supply services.engagement30 Jun 2026scheduled

Related procurements

No linked framework, prior procurement or reprocurement published.

Documents & submission route

Source data inventory

Diagnostic view. “Not published” means this current release does not provide a value.

OCIDocds-h6vhtk-06a701
Latest release ID050047-2026
Latest release timestampThu May 28 2026 08:22:35 GMT+0000 (Coordinated Universal Time)
Sourcefind-a-tender
Official notice URLNot published
Tender statusplanning
Procurement methodNot published
Procurement method detailsNot published
Main procurement categoryservices
Above thresholdYes
Legal basis2023/54
Tender period: startNot published
Tender period: endNot published
Expression of interest deadlineNot published
Enquiry deadlineNot published
Award period: startNot published
Award period: endNot published
Submission method detailsNot published
Submission languagesNot published
Electronic catalogue policyNot published
Total tender valueNot published
Tender lots in source1
Tender items in source1
Tender documents in source0
Awards in latest release0
Contracts in latest release0
Parties in latest release1

Notice history

DateEventReference
28 May 2026planningUpdate050047-2026
28 May 2026planning050038-2026

All source data

Unmodified official OCDS data retained by Tenderline for this procurement process.

Complete current OCDS release JSON
{
  "id": "050047-2026",
  "tag": [
    "planningUpdate"
  ],
  "date": "2026-05-28T09:22:35+01:00",
  "ocid": "ocds-h6vhtk-06a701",
  "buyer": {
    "id": "GB-PPON-PXRL-3879-BBGR",
    "name": "Royal United Hospitals Bath NHS Foundation Trust"
  },
  "tender": {
    "id": "C449972",
    "lots": [
      {
        "id": "1",
        "status": "planning",
        "contractPeriod": {
          "endDate": "2037-06-01T23:59:59+01:00",
          "startDate": "2027-01-01T00:00:00Z"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "additionalClassifications": [
          {
            "id": "85149000",
            "scheme": "CPV",
            "description": "Pharmacy services"
          },
          {
            "id": "09344000",
            "scheme": "CPV",
            "description": "Radio-isotopes"
          },
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          },
          {
            "id": "33690000",
            "scheme": "CPV",
            "description": "Various medicinal products"
          },
          {
            "id": "09343000",
            "scheme": "CPV",
            "description": "Radioactive materials"
          }
        ]
      }
    ],
    "title": "Soft Market Testing Radiopharmacy Services Joint Venture",
    "status": "planning",
    "amendments": [
      {
        "id": "050047-2026",
        "description": "Adding of Portal link"
      }
    ],
    "legalBasis": {
      "id": "2023/54",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
      "scheme": "UKPGA"
    },
    "description": "The Royal United Hospitals NHS Foundation Trust is exploring options to expand its Radiopharmacy Services to improve access to diagnostics, innovative treatment and research in Southwest England. \nUniquely positioned on the M4/M5 corridor, the Trust has a state-of-the-art Pharmacy build intended to provide a comprehensive range of services including:\n1. Cytotoxics (191 sq ft): mainly production of systemic anticancer therapy (SACT) and clinical trials for Onc/Haem\n2. Monoclonal antibodies (180 sq ft): products for Biologics unit and chemo unit\n3. Radiopharmacy unit (279sq ft): supply for Nuclear medicine diagnostics & treatment\n4. Vacant clean room space originally intended for Gene Therapy (108 sq ft) \nAs part of this appraisal, the Trust is evaluating a range of potential delivery and funding models, including the possibility of a Joint Venture or other form of partnership with a private sector organisation.\nThe purpose of this soft market testing exercise is to gain insight into:\n• The level of interest from suppliers and investors in collaborating with the Trust\n• The range of commercial, technical and operational models available within the market \n• Key risks, dependencies and potential mitigation approaches\n• Options that best ensure service continuity \n• Indicative timelines and delivery pathways \nThis exercise is being undertaken for information gathering purposes only and does not constitute a call for competition or form part of any formal procurement process. The responses received will be used to inform the Trust’s approach and any potential future procurement activity.\nPlease note, Royal United Hospitals Bath NHS Foundation Trust reserves the right not to proceed with the procurement once this Pre-Engagement stage has been finalised.",
    "aboveThreshold": true,
    "mainProcurementCategory": "services"
  },
  "parties": [
    {
      "id": "GB-PPON-PXRL-3879-BBGR",
      "name": "Royal United Hospitals Bath NHS Foundation Trust",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKK12",
        "country": "GB",
        "locality": "Bath",
        "postalCode": "BA1 3NG",
        "countryName": "United Kingdom",
        "streetAddress": "Procurement Team, E9 Mezzanine, Combe Park"
      },
      "details": {
        "url": "https://www.ruh.nhs.uk/",
        "classifications": [
          {
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE",
            "description": "Public authority - central government"
          }
        ]
      },
      "identifier": {
        "id": "PXRL-3879-BBGR",
        "scheme": "GB-PPON"
      },
      "contactPoint": {
        "email": "henry.prudden@nhs.net",
        "telephone": "01722336262"
      }
    }
  ],
  "language": "en",
  "planning": {
    "documents": [
      {
        "id": "050047-2026",
        "url": "https://www.find-tender.service.gov.uk/Notice/050047-2026",
        "format": "text/html",
        "noticeType": "UK2",
        "description": "Preliminary market engagement notice on Find a Tender",
        "documentType": "marketEngagementNotice",
        "datePublished": "2026-05-28T09:22:35+01:00"
      }
    ],
    "milestones": [
      {
        "id": "engagement",
        "type": "engagement",
        "status": "scheduled",
        "dueDate": "2026-06-30T23:59:59+01:00",
        "description": "Engagement with interested suppliers will be conducted on a one-to-one basis during the week commencing 15th and 22nd June. This will include an invite to a face-to-face meeting, along with an opportunity to visit and tour the Aseptic Unit.\nInterested parties are invited to express their interest via the Health service Family portal - https://atamis-1928.my.site.com/s/Welcome \nPlease include a brief overview of your organisation, relevant experience and strategic ambition in Radiopharmaceutical supply services."
      }
    ]
  },
  "initiationType": "tender"
}
Complete JSON history (2 releases)
28 May 2026 · 050047-2026 · planningUpdate
{
  "id": "050047-2026",
  "tag": [
    "planningUpdate"
  ],
  "date": "2026-05-28T09:22:35+01:00",
  "ocid": "ocds-h6vhtk-06a701",
  "buyer": {
    "id": "GB-PPON-PXRL-3879-BBGR",
    "name": "Royal United Hospitals Bath NHS Foundation Trust"
  },
  "tender": {
    "id": "C449972",
    "lots": [
      {
        "id": "1",
        "status": "planning",
        "contractPeriod": {
          "endDate": "2037-06-01T23:59:59+01:00",
          "startDate": "2027-01-01T00:00:00Z"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "additionalClassifications": [
          {
            "id": "85149000",
            "scheme": "CPV",
            "description": "Pharmacy services"
          },
          {
            "id": "09344000",
            "scheme": "CPV",
            "description": "Radio-isotopes"
          },
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          },
          {
            "id": "33690000",
            "scheme": "CPV",
            "description": "Various medicinal products"
          },
          {
            "id": "09343000",
            "scheme": "CPV",
            "description": "Radioactive materials"
          }
        ]
      }
    ],
    "title": "Soft Market Testing Radiopharmacy Services Joint Venture",
    "status": "planning",
    "amendments": [
      {
        "id": "050047-2026",
        "description": "Adding of Portal link"
      }
    ],
    "legalBasis": {
      "id": "2023/54",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
      "scheme": "UKPGA"
    },
    "description": "The Royal United Hospitals NHS Foundation Trust is exploring options to expand its Radiopharmacy Services to improve access to diagnostics, innovative treatment and research in Southwest England. \nUniquely positioned on the M4/M5 corridor, the Trust has a state-of-the-art Pharmacy build intended to provide a comprehensive range of services including:\n1. Cytotoxics (191 sq ft): mainly production of systemic anticancer therapy (SACT) and clinical trials for Onc/Haem\n2. Monoclonal antibodies (180 sq ft): products for Biologics unit and chemo unit\n3. Radiopharmacy unit (279sq ft): supply for Nuclear medicine diagnostics & treatment\n4. Vacant clean room space originally intended for Gene Therapy (108 sq ft) \nAs part of this appraisal, the Trust is evaluating a range of potential delivery and funding models, including the possibility of a Joint Venture or other form of partnership with a private sector organisation.\nThe purpose of this soft market testing exercise is to gain insight into:\n• The level of interest from suppliers and investors in collaborating with the Trust\n• The range of commercial, technical and operational models available within the market \n• Key risks, dependencies and potential mitigation approaches\n• Options that best ensure service continuity \n• Indicative timelines and delivery pathways \nThis exercise is being undertaken for information gathering purposes only and does not constitute a call for competition or form part of any formal procurement process. The responses received will be used to inform the Trust’s approach and any potential future procurement activity.\nPlease note, Royal United Hospitals Bath NHS Foundation Trust reserves the right not to proceed with the procurement once this Pre-Engagement stage has been finalised.",
    "aboveThreshold": true,
    "mainProcurementCategory": "services"
  },
  "parties": [
    {
      "id": "GB-PPON-PXRL-3879-BBGR",
      "name": "Royal United Hospitals Bath NHS Foundation Trust",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKK12",
        "country": "GB",
        "locality": "Bath",
        "postalCode": "BA1 3NG",
        "countryName": "United Kingdom",
        "streetAddress": "Procurement Team, E9 Mezzanine, Combe Park"
      },
      "details": {
        "url": "https://www.ruh.nhs.uk/",
        "classifications": [
          {
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE",
            "description": "Public authority - central government"
          }
        ]
      },
      "identifier": {
        "id": "PXRL-3879-BBGR",
        "scheme": "GB-PPON"
      },
      "contactPoint": {
        "email": "henry.prudden@nhs.net",
        "telephone": "01722336262"
      }
    }
  ],
  "language": "en",
  "planning": {
    "documents": [
      {
        "id": "050047-2026",
        "url": "https://www.find-tender.service.gov.uk/Notice/050047-2026",
        "format": "text/html",
        "noticeType": "UK2",
        "description": "Preliminary market engagement notice on Find a Tender",
        "documentType": "marketEngagementNotice",
        "datePublished": "2026-05-28T09:22:35+01:00"
      }
    ],
    "milestones": [
      {
        "id": "engagement",
        "type": "engagement",
        "status": "scheduled",
        "dueDate": "2026-06-30T23:59:59+01:00",
        "description": "Engagement with interested suppliers will be conducted on a one-to-one basis during the week commencing 15th and 22nd June. This will include an invite to a face-to-face meeting, along with an opportunity to visit and tour the Aseptic Unit.\nInterested parties are invited to express their interest via the Health service Family portal - https://atamis-1928.my.site.com/s/Welcome \nPlease include a brief overview of your organisation, relevant experience and strategic ambition in Radiopharmaceutical supply services."
      }
    ]
  },
  "initiationType": "tender"
}
28 May 2026 · 050038-2026 · planning
{
  "id": "050038-2026",
  "tag": [
    "planning"
  ],
  "date": "2026-05-28T09:17:55+01:00",
  "ocid": "ocds-h6vhtk-06a701",
  "buyer": {
    "id": "GB-PPON-PXRL-3879-BBGR",
    "name": "Royal United Hospitals Bath NHS Foundation Trust"
  },
  "tender": {
    "id": "C449972",
    "lots": [
      {
        "id": "1",
        "status": "planning",
        "contractPeriod": {
          "endDate": "2037-06-01T23:59:59+01:00",
          "startDate": "2027-01-01T00:00:00Z"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "additionalClassifications": [
          {
            "id": "85149000",
            "scheme": "CPV",
            "description": "Pharmacy services"
          },
          {
            "id": "09344000",
            "scheme": "CPV",
            "description": "Radio-isotopes"
          },
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          },
          {
            "id": "33690000",
            "scheme": "CPV",
            "description": "Various medicinal products"
          },
          {
            "id": "09343000",
            "scheme": "CPV",
            "description": "Radioactive materials"
          }
        ]
      }
    ],
    "title": "Soft Market Testing Radiopharmacy Services Joint Venture",
    "status": "planning",
    "legalBasis": {
      "id": "2023/54",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
      "scheme": "UKPGA"
    },
    "description": "The Royal United Hospitals NHS Foundation Trust is exploring options to expand its Radiopharmacy Services to improve access to diagnostics, innovative treatment and research in Southwest England. \nUniquely positioned on the M4/M5 corridor, the Trust has a state-of-the-art Pharmacy build intended to provide a comprehensive range of services including:\n1. Cytotoxics (191 sq ft): mainly production of systemic anticancer therapy (SACT) and clinical trials for Onc/Haem\n2. Monoclonal antibodies (180 sq ft): products for Biologics unit and chemo unit\n3. Radiopharmacy unit (279sq ft): supply for Nuclear medicine diagnostics & treatment\n4. Vacant clean room space originally intended for Gene Therapy (108 sq ft) \nAs part of this appraisal, the Trust is evaluating a range of potential delivery and funding models, including the possibility of a Joint Venture or other form of partnership with a private sector organisation.\nThe purpose of this soft market testing exercise is to gain insight into:\n• The level of interest from suppliers and investors in collaborating with the Trust\n• The range of commercial, technical and operational models available within the market \n• Key risks, dependencies and potential mitigation approaches\n• Options that best ensure service continuity \n• Indicative timelines and delivery pathways \nThis exercise is being undertaken for information gathering purposes only and does not constitute a call for competition or form part of any formal procurement process. The responses received will be used to inform the Trust’s approach and any potential future procurement activity.\nPlease note, Royal United Hospitals Bath NHS Foundation Trust reserves the right not to proceed with the procurement once this Pre-Engagement stage has been finalised.",
    "aboveThreshold": true,
    "mainProcurementCategory": "services"
  },
  "parties": [
    {
      "id": "GB-PPON-PXRL-3879-BBGR",
      "name": "Royal United Hospitals Bath NHS Foundation Trust",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKK12",
        "country": "GB",
        "locality": "Bath",
        "postalCode": "BA1 3NG",
        "countryName": "United Kingdom",
        "streetAddress": "Procurement Team, E9 Mezzanine, Combe Park"
      },
      "details": {
        "url": "https://www.ruh.nhs.uk/",
        "classifications": [
          {
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE",
            "description": "Public authority - central government"
          }
        ]
      },
      "identifier": {
        "id": "PXRL-3879-BBGR",
        "scheme": "GB-PPON"
      },
      "contactPoint": {
        "email": "henry.prudden@nhs.net",
        "telephone": "01722336262"
      }
    }
  ],
  "language": "en",
  "planning": {
    "documents": [
      {
        "id": "050038-2026",
        "url": "https://www.find-tender.service.gov.uk/Notice/050038-2026",
        "format": "text/html",
        "noticeType": "UK2",
        "description": "Preliminary market engagement notice on Find a Tender",
        "documentType": "marketEngagementNotice",
        "datePublished": "2026-05-28T09:17:55+01:00"
      }
    ],
    "milestones": [
      {
        "id": "engagement",
        "type": "engagement",
        "status": "scheduled",
        "dueDate": "2026-06-30T23:59:59+01:00",
        "description": "Engagement with interested suppliers will be conducted on a one-to-one basis during the week commencing 15th and 22nd June. This will include an invite to a face-to-face meeting, along with an opportunity to visit and tour the Aseptic Unit.\nInterested parties are invited to express their interest via the Health service Family portal.  \nPlease include a brief overview of your organisation, relevant experience and strategic ambition in Radiopharmaceutical supply services."
      }
    ]
  },
  "initiationType": "tender"
}